Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
-
- Gboyega Adeboyeje
- HealthCore, Wilmington, Delaware.
-
- Gosia Sylwestrzak
- HealthCore, Wilmington, Delaware.
-
- John J. Barron
- HealthCore, Wilmington, Delaware.
-
- Jeff White
- Anthem, Indianapolis, Indiana.
-
- Alan Rosenberg
- Anthem, Indianapolis, Indiana.
-
- Jacob Abarca
- Anthem, Indianapolis, Indiana.
-
- Geoffrey Crawford
- Anthem, Indianapolis, Indiana.
-
- Rita Redberg
- University of California, San Francisco.
収録刊行物
-
- Journal of Managed Care & Specialty Pharmacy
-
Journal of Managed Care & Specialty Pharmacy 23 (9), 968-978, 2017-09
Academy of Managed Care Pharmacy